RetinalGenix Technologies Inc. (RTGN): Total Liabilities

Annual figures by period end, from SEC filings.

$2.32M
As of 2025-12-31
$2.67M
As of 2026-06-30
+29.5%
3-year compound annual growth
+75.0%
5-year compound annual growth
2020-12-31: $141.4K2021-12-31: $469.6K2022-12-31: $1.07M2023-12-31: $1.41M2024-12-31: $1.48M2025-12-31: $2.32M$2.32M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$2.32M+57.3%2026-04-15, Balance as of period end
2024-12-31$1.48M+5.1%2026-04-15, Balance as of period end
2023-12-31$1.41M+31.5%2025-03-31, Balance as of period end
2022-12-31$1.07M+127.7%2024-04-01, Balance as of period end
2021-12-31$469.6K+232.1%2023-06-15, Balance as of period end
2020-12-31$141.4Kn/a2022-04-15, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
RetinalGenix Technologies Inc. (RTGN)2025-12-31$2.32M+57.3%
ALR Technologies SG Ltd. (ALRTF)2025-12-31$39.91M+9.9%
Nu-Med Plus, Inc. (NUMD)2025-12-31$279.2K+24.4%
Stimcell Energetics Inc. (STME)2026-05-31$1.89M+49.3%
Global Innovative Platforms Inc. (GIPL)2025-09-30$11.6K-65.0%
Sigyn Therapeutics, Inc. (SIGY)2024-12-31$4.67M+25.1%
Vycor Medical Inc (VYCO)2025-12-31$4.92M+4.9%
Mountain Crest Acquisition Corp. V (MCAG)2025-12-31$3.72M+3.7%
Family Office of America, Inc. (FOFA)2025-12-31$878.5Kn/m

Compare RTGN, ALRTF, NUMD, STME side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗